High Intensity Interval Training in Patients With Glaucoma

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

HIT GLAUCOMA is a multicenter exercise study for glaucoma patients between three institutes: the Department of Sport, Exercise and Health (DSBG) of the University of Basel, the Eye Clinic at the University Hospital Basel and the UZ Leuven (Belgium). The main objective of the study is to investigate the possibility of using exercise therapy to treat glaucoma. Participants will be randomly divided into two groups: Intervention and Control group. The intervention group will receive a high-intensity interval training plan, and the control group will receive lifestyle counseling and standard therapy. With this method, the study aims to validate an exercise therapy concept that could significantly improve disease progression and quality of life in patients with glaucoma.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 40
Maximum Age: 80
Healthy Volunteers: f
View:

• Voluntary written informed consent of the participant has been obtained prior to any screening procedures

• Patients with primary open angle glaucoma (POAG), high tension glaucoma (HTG) and normal tension glaucoma (NTG), aged 40 - 75 years

• In regular follow-up in either of the two study centres

Locations
Other Locations
Switzerland
University of Basel, Department of Sport, Exercise & Health
RECRUITING
Basel
Contact Information
Primary
Henner Hanssen, Prof. Dr.
henner.hanssen@unibas.ch
+41 61 207 47 46
Time Frame
Start Date: 2023-12-01
Estimated Completion Date: 2026-09-30
Participants
Target number of participants: 168
Treatments
Experimental: Intervention Group
Group performing exercise training and receiving standard care
Experimental: Control Group
Group receiving lifestyle counseling and receiving standard care
Sponsors
Leads: Henner Hanssen
Collaborators: Universitaire Ziekenhuizen KU Leuven, University Hospital, Basel, Switzerland

This content was sourced from clinicaltrials.gov